Navigation Links
Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments
Date:9/24/2008

Lilly CEO Lechleiter detailed registry plans at Indianapolis speech

INDIANAPOLIS, Sept. 24 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY) announced that it is set to become the first pharmaceutical research company to disclose its payments to physicians in the United States.

At a speech before the Economic Club of Indiana today, Lilly's president and chief executive officer, John Lechleiter, Ph.D., outlined the company's plans to launch an online registry of physician payments in 2009. Lechleiter announced the physician registry as a part of a broader outline on the company's transformation efforts.

"With each of our industry firsts, from launching our clinical trials registry to the public reporting of educational grants, Lilly is striving to be a leader in improving transparency across our industry," said Lechleiter. "As Lilly continues to look for more ways to be open and transparent about our business, we've learned that letting people see for themselves what we're doing is the best way to build trust."

Earlier this year, Lilly was the first pharmaceutical research company to endorse bipartisan federal legislation - known as the Physician Payments Sunshine Act - that would establish a national registry of payments to physicians by medical device, medical supply and pharmaceutical companies. The legislation, which was introduced by United States Senators Charles Grassley (R-Iowa) and Herbert Kohl (D-Wisconsin) last September, has not been passed yet by Congress.

Lechleiter added, "Though we remain hopeful that the Sunshine Act will be passed by Congress at some point, Lilly is taking action independently. Being more transparent by opening up our business to the public is an important step to building trust and confidence."

Under the Lilly registry plan, the public will have access to an Internet database listing its payments to physicians. Lilly will launch this registry as early as the second half of 2009. When first launched, its contents will include 2009 payments to physicians who serve the company as speakers and advisors. By 2011, Lilly plans to expand the reporting capabilities of the registry to resemble the Sunshine Act legislation. The registry will be updated annually to reflect the previous year's payment information.

"Eli Lilly is leading the charge for transparency in the relationship between pharmaceutical companies and doctors by fulfilling the obligations of the Physician Payments Sunshine Act before it has been enacted," said Senator Kohl. "It takes a lot of courage to be the first. They have made a principled decision that I believe will benefit both their business and the consumers of their products."

"Lilly is proud of the important and longstanding relationships we have with physicians," said Lechleiter. "Many physicians perform valuable services for the biopharmaceutical industry by advising us on the development of new medicines and giving lectures to other medical professionals to educate them about new treatment options. For these services, they are compensated at market rates. These services help to advance the science related to medicines and are important to both current and future patients who rely on pharmaceuticals as an integral part of their therapy."

"Our primary focus is the well-being of our patients and APA has adopted strict disclosure policies to ensure our patients are informed regarding relationships between physicians and industry," said James H. Scully Jr., M.D., CEO and Medical Director of the American Psychiatric Association. "We applaud efforts by Lilly to ensure there is transparency in their relationships with physicians."

Lilly's plan to create a physicians payments registry is consistent with other voluntary actions it has taken recently to enhance transparency in health care, including its support of the Physician Payments Sunshine Act. In 2004, Lilly became the first company to voluntarily make public its clinical trials and its clinical trials data; that information can be found at http://www.lillytrials.com. Last year Lilly added another first by publicly reporting all of its educational grants and charitable contributions and, each quarter, posting the data online at http://www.lillygrantoffice.com.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly and Amylin Set Date and Time for Conference Call
2. Covance and Lilly Enter Into a Strategic R&D Collaboration
3. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
4. Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country
5. Lilly Partners With the National Council of La Raza to Fight Chronic Disease
6. Lilly Supports Industry Code on Interactions with Healthcare Professionals
7. AUDIO from Medialink, Eli Lilly and the American Association of Clinical Endocrinologists: Dont let Natural Disasters Leave you Without Needed Medications
8. Lilly Declares Third-Quarter Dividend
9. Lilly to Provide Aid to Indiana Tornado and Flood Victims
10. Lilly Announces Changes in Key Leadership Roles
11. AUDIO from Medialink and Eli Lilly and Company: F.A.C.E. Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... In ... taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, ... overseas retirement havens have extremely low property-tax rates, which contributes to the relatively ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology: